Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy

Por Fukui, Shoichi, Nakamura, Hideki, Takahashi, Yoshiko, Iwamoto, Naoki, Hasegawa, Hiroo, Yanagihara, Katsunori, Nakamura, Tatsufumi, Okayama, Akihiko, Kawakami, Atsushi
Publicado no BMC Immunol (2017)

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP

Por Araya, Natsumi, Sato, Tomoo, Utsunomiya, Atae, Ando, Hitoshi, Yagishita, Naoko, Kannagi, Mari, Nakamura, Tatsufumi, Tanaka, Yuetsu, Jacobson, Steven, Yamano, Yoshihisa
Publicado em 2011

Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren’s syndrome

Por Nakamura, Hideki, Shimizu, Toshimasa, Takagi, Yukinori, Takahashi, Yoshiko, Horai, Yoshiro, Nakashima, Yoshikazu, Sato, Shuntaro, Shiraishi, Hirokazu, Nakamura, Tatsufumi, Fukuoka, Junya, Nakamura, Takashi, Kawakami, Atsushi
Publicado no BMC Musculoskelet Disord (2015)

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial

Por Nakamura, Tatsufumi, Matsuo, Tomohiro, Fukuda, Taku, Yamato, Shinji, Yamaguchi, Kentaro, Kinoshita, Ikuo, Matsuzaki, Toshio, Nishiura, Yoshihiro, Nagasato, Kunihiko, Narita-Masuda, Tomoko, Nakamura, Hideki, Satoh, Katsuya, Sasaki, Hitoshi, Sakai, Hideki, Kawakami, Atsushi
Publicado em 2013